文献速递复苏、休克与脓毒症儿科与产科急症

肾上腺素生理反应与儿童心肺复苏结局

The physiologic response to epinephrine and pediatric cardiopulmonary resuscitation outcomes.
PubMed 文献 · Crit Care · 2023-03-13
一句话结论儿童院内心肺复苏中,肾上腺素后舒张压升高≥5 mmHg与自主循环恢复相关(aRR 1.60 [1.21, 2.12];p=0.001)。

本研究为ICU-RESUS试验(NCT02837497)18个ICU的前瞻性多中心研究,纳入147例接受≥1分钟心肺复苏且≥1剂肾上腺素、有可评估有创动脉血压数据的患儿。逐次按压定量分析血压波形,比较首剂肾上腺素前与给药后2分钟的平均舒张压;舒张压升高≥5 mmHg定义为有反应者。66例(45%)为有反应者,81例(55%)为无反应者;肾上腺素后舒张压平均升高4.4 [-1.9, 11.5] mmHg(有反应者13.6 [7.5, 29.3] mmHg vs 无反应者-1.5 [-5.0, 1.5] mmHg;p < 0.001)。校正预设协变量后,肾上腺素反应与自主循环恢复相关(aRR 1.60 [1.21, 2.12];p = 0.001);敏感性分析显示舒张压反应阈值≥10、15、20 mmHg与自主循环恢复有相似关联,≥10和≥15 mmHg与出院存活率更高及神经功能预后良好存活率更高相关。

要点

  • 儿童院内心肺复苏中,肾上腺素后舒张压升高≥5 mmHg者为有反应者,占45%(66/147);无反应者占55%(81/147)。
  • 校正预设协变量后,肾上腺素反应与自主循环恢复相关:aRR 1.60 [1.21, 2.12];p = 0.001。
  • 敏感性分析中,舒张压反应阈值≥10、15、20 mmHg与自主循环恢复有相似关联。
  • 舒张压反应≥10和≥15 mmHg与出院存活率更高及神经功能预后良好存活率更高相关(Pediatric Cerebral Performance Category评分1-3分或较基线无恶化)。

适用人群与场景

  • ICU-RESUS试验(NCT02837497)18个ICU中接受≥1分钟心肺复苏、≥1剂肾上腺素且有可评估有创动脉血压数据的患儿。

诊断标准与关键阈值

  • 有反应者定义为首剂肾上腺素后2分钟平均舒张压较给药前升高≥5 mmHg。
  • 敏感性分析评估的舒张压反应阈值包括≥10、≥15、≥20 mmHg。
  • 神经功能预后良好定义为Pediatric Cerebral Performance Category评分1-3分或较基线无恶化。

研究设计与关键结果

  • 研究类型:前瞻性多中心研究,纳入147例患儿,来自ICU-RESUS试验的18个ICU。
  • 有反应者66例(45%),无反应者81例(55%)。
  • 肾上腺素后舒张压平均升高4.4 [-1.9, 11.5] mmHg;有反应者升高13.6 [7.5, 29.3] mmHg,无反应者变化-1.5 [-5.0, 1.5] mmHg;p < 0.001。
  • 校正预设协变量后,肾上腺素反应与自主循环恢复相关:aRR 1.60 [1.21, 2.12];p = 0.001。
  • 敏感性分析:舒张压反应阈值≥10、15、20 mmHg与自主循环恢复有相似关联;≥10和≥15 mmHg与出院存活率更高及神经功能预后良好存活率更高相关。

证据类型、等级与局限

  • 证据类型:前瞻性多中心研究(ICU-RESUS试验的子研究)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 儿童院内心肺复苏中,给予肾上腺素后2分钟舒张压较给药前升高≥5 mmHg与自主循环恢复相关(aRR 1.60 [1.21, 2.12];p = 0.001)。
  • 舒张压反应阈值≥10和≥15 mmHg与出院存活率更高及神经功能预后良好存活率更高相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Epinephrine is provided during cardiopulmonary resuscitation (CPR) to increase systemic vascular resistance and generate higher diastolic blood pressure (DBP) to improve coronary perfusion and attain return of spontaneous circulation (ROSC). The DBP response to epinephrine during pediatric CPR and its association with outcomes have not been well described. Thus, the objective of this study was to measure the association between change in DBP after epinephrine administration during CPR and ROSC.

METHODS: This was a prospective multicenter study of children receiving ≥ 1 min of CPR with ≥ 1 dose of epinephrine and evaluable invasive arterial BP data in the 18 ICUs of the ICU-RESUS trial (NCT02837497). Blood pressure waveforms underwent compression-by-compression quantitative analysis. The mean DBP before first epinephrine dose was compared to mean DBP two minutes post-epinephrine. Patients with ≥ 5 mmHg increase in DBP were characterized as "responders."

RESULTS: Among 147 patients meeting inclusion criteria, 66 (45%) were characterized as responders and 81 (55%) were non-responders. The mean increase in DBP with epinephrine was 4.4 [- 1.9, 11.5] mmHg (responders: 13.6 [7.5, 29.3] mmHg versus non-responders: - 1.5 [- 5.0, 1.5] mmHg; p < 0.001). After controlling for a priori selected covariates, epinephrine response was associated with ROSC (aRR 1.60 [1.21, 2.12]; p = 0.001). Sensitivity analyses identified similar associations between DBP response thresholds of ≥ 10, 15, and 20 mmHg and ROSC; DBP responses of ≥ 10 and ≥ 15 mmHg were associated with higher aRR of survival to hospital discharge and survival with favorable neurologic outcome (Pediatric Cerebral Performance Category score of 1-3 or no worsening from baseline).

CONCLUSIONS: The change in DBP following epinephrine administration during pediatric in-hospital CPR was associated with return of spontaneous circulation.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Morgan RW, Berg RA, Reeder RW, et al. The physiologic response to epinephrine and pediatric cardiopulmonary resuscitation outcomes. Crit Care. 2023. PMID: 36915182. doi:10.1186/s13054-023-04399-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。